Brief: Galecto Inc Estimates That It Will Incur Approximately $2.8 Mln In Restructuring Charges

Damora Therapeutics

26/09/2023 23:26

Sept 26 (Reuters) - Galecto Inc  GLTO.O :
    * GALECTO INC - ESTIMATES THAT IT WILL INCUR APPROXIMATELY
$2.8
MILLION IN RESTRUCTURING CHARGES IN CONNECTION WITH
RESTRUCTURING
    * GALECTO INC - COMPANY EXPECTS THAT MAJORITY OF
RESTRUCTURING
CHARGES WILL BE INCURRED IN Q3 OF 2023
    * GALECTO INC - EXECUTION OF RESTRUCTURING PLAN WILL BE
SUBSTANTIALLY COMPLETE BY END OF Q4 OF 2023
    * GALECTO - ON SEPT 21, TOLD BERTIL LINDMARK CHIEF MEDICAL
OFFICER, HIS POSITION WILL BE ELIMINATED AND HIS DUTIES WILL BE
ASSUMED BY HANS SCHAMBYE

Further company coverage:  GLTO.O 

 ((Reuters.briefs@thomsonreuters.com;))